Trials / Unknown
UnknownNCT02621723
Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group
Capturing Readmission Internationally to Prevent Readmission by Safer@Home
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Amsterdam UMC, location VUmc · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
CURIOS@ is a prospective multi-centre cross-sectional study to investigate readmissions in participating units. The data collected is derived from two clinical episodes: the episode containing the re-admission and the previous admission (index admission). The main aims are: Outcomes: * Risk factors to predict preventable readmissions in non-surgical patients * Percentage of subjectively non-preventable and preventable readmissions from patient, carer, their nurses and their physician's point of view * Comparison for risk factors on readmissions throughout Europe * Increasing awareness and knowledge for health-care workers on readmissions and its preventability
Detailed description
Data will be derived directly from patients, from the clinical notes of the previous admission and records of discharge communication. Also information from treating physicians, nurses and immediate caregivers will be collected. The data set will contain no directly identifiable variables (data will be registered by using a research code for each patient). Data collection will include: Hospital-related data, patient-related data, health-related data, time-related data, and physician related data. Also patient feedback is requested. After obtaining written informed consent, the researcher will ask the patient 7 questions about the (preventability of their) readmission. Also the patient will be asked if one of the direct carers can be approached with 2 questions. The carer will most often be a sibling, a good friend or someone from the neighborhood. We will approach the carer in person or by telephone, and only after explicit permission from the patient. Lastly, we will ask a doctor and nurse (responsible for the patient in the first 24 hours of his readmission) similar questions.
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-01-01
- Completion
- 2018-01-01
- First posted
- 2015-12-03
- Last updated
- 2015-12-03
Locations
8 sites across 3 countries: Denmark, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02621723. Inclusion in this directory is not an endorsement.